Our focus now is to ensure eligible older adults in the US can access the vaccine as quickly as possible,” said Tony Wood, the chief scientific officer at GSK.
Read Full Story at source (may require registration)
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024
- FTSE 100 Modestly Higher In Cautious Trade - November 27, 2024
- CAC 40 Slides As French Risk Premium Peaks - November 27, 2024